Literature DB >> 21304105

Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S.

Felicity N E Gavins1, Janice Russell, Elena L Senchenkova, Lidiana De Almeida Paula, Amílcar S Damazo, Charles T Esmon, Daniel Kirchhofer, Robert P Hebbel, D Neil Granger.   

Abstract

The microvasculature assumes an inflammatory and procoagulant state in a variety of different diseases, including sickle cell disease (SCD), which may contribute to the high incidence of ischemic stroke in these patients. This study provides evidence for accelerated thrombus formation in arterioles and venules in the cerebral vasculature of mice that express hemoglobin-S (β(s) mice). Enhanced microvascular thrombosis in β(s) mice was blunted by immunologic or genetic interventions that target tissue factor, endothelial protein C receptor, activated protein C, or thrombin. Platelets from β(s) mice also exhibited enhanced aggregation velocity after stimulation with thrombin but not ADP. Neutropenia also protected against the enhanced thrombosis response in β(s) mice. These results indicate that the cerebral microvasculature is rendered vulnerable to thrombus formation in β(s) mice via a neutrophil-dependent mechanism that is associated with an increased formation of and enhanced platelet sensitivity to thrombin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21304105      PMCID: PMC3087535          DOI: 10.1182/blood-2010-08-301366

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  54 in total

1.  Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice.

Authors:  J David Holtzclaw; Daniel Jack; Samuel M Aguayo; James R Eckman; Jesse Roman; Lewis L Hsu
Journal:  Am J Respir Crit Care Med       Date:  2003-12-18       Impact factor: 21.405

2.  Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.

Authors:  J Kurantsin-Mills; F A Ofosu; T K Safa; R S Siegel; L S Lessin
Journal:  Br J Haematol       Date:  1992-08       Impact factor: 6.998

Review 3.  The evolving paradigm for blood cell-endothelial cell interactions in the cerebral microcirculation.

Authors:  Felicity Gavins; Gokhan Yilmaz; D Neil Granger
Journal:  Microcirculation       Date:  2007 Sep-Oct       Impact factor: 2.628

4.  Protein C and protein S in homozygous sickle cell disease: does hepatic dysfunction contribute to low levels?

Authors:  J G Wright; R Malia; P Cooper; P Thomas; F E Preston; G R Serjeant
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

5.  Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a TLR4-dependent, neutrophil-independent mechanism.

Authors:  Rolando E Rumbaut; Ricardo V Bellera; Jaspreet K Randhawa; Corie N Shrimpton; Swapan K Dasgupta; Jing-Fei Dong; Alan R Burns
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-11-11       Impact factor: 4.733

6.  Pathophysiology of a sickle cell trait mouse model: human alpha(beta)(S) transgenes with one mouse beta-globin allele.

Authors:  C T Noguchi; M Gladwin; B Diwan; P Merciris; R Smith; X Yu; G Buzard; A Fitzhugh; L K Keefer; A N Schechter; N Mohandas
Journal:  Blood Cells Mol Dis       Date:  2001 Nov-Dec       Impact factor: 3.039

7.  Morphological and functional platelet abnormalities in Berkeley sickle cell mice.

Authors:  Arun S Shet; Thomas J Hoffmann; Marketa Jirouskova; Christin A Janczak; Jacqueline R M Stevens; Adewole Adamson; Narla Mohandas; Elizabeth A Manci; Therese Cynober; Barry S Coller
Journal:  Blood Cells Mol Dis       Date:  2008-04-18       Impact factor: 3.039

8.  Anti-thrombin III deficiency in Nigerian children with sickle cell disease. Possible role in the cerebral syndrome.

Authors:  G C Onyemelukwe; H B Jibril
Journal:  Trop Geogr Med       Date:  1992-01

9.  Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin.

Authors:  Neil M Matsui; Ajit Varki; Stephen H Embury
Journal:  Blood       Date:  2002-07-05       Impact factor: 22.113

Review 10.  Hypercoagulability in sickle cell disease: a curious paradox.

Authors:  Kenneth I Ataga; Eugene P Orringer
Journal:  Am J Med       Date:  2003-12-15       Impact factor: 4.965

View more
  25 in total

1.  Targeting of Formyl Peptide Receptor 2 for in vivo imaging of acute vascular inflammation.

Authors:  Tamara Boltersdorf; Junaid Ansari; Elena Y Senchenkova; Jieny Groeper; Denise Pajonczyk; Shantel A Vital; Gaganpreet Kaur; J Steve Alexander; Thomas Vogl; Ursula Rescher; Nicholas J Long; Felicity N E Gavins
Journal:  Theranostics       Date:  2020-05-17       Impact factor: 11.556

2.  P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice.

Authors:  Roxane Darbousset; Céline Delierneux; Soraya Mezouar; Alexandre Hego; Christelle Lecut; Isabelle Guillaumat; Markus A Riederer; Richard J Evans; Françoise Dignat-George; Laurence Panicot-Dubois; Cécile Oury; Christophe Dubois
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

3.  The isothiocyanate sulforaphane modulates platelet function and protects against cerebral thrombotic dysfunction.

Authors:  Scarlett Gillespie; Paul M Holloway; Felix Becker; Francesca Rauzi; Shantel A Vital; Kirk A Taylor; Karen Y Stokes; Michael Emerson; Felicity N E Gavins
Journal:  Br J Pharmacol       Date:  2018-07-03       Impact factor: 8.739

Review 4.  Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.

Authors:  Junaid Ansari; Youmna E Moufarrej; Rafal Pawlinski; Felicity N E Gavins
Journal:  Expert Rev Hematol       Date:  2017-12-05       Impact factor: 2.929

5.  Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease.

Authors:  Erica M Sparkenbaugh; Pichika Chantrathammachart; Jacqueline Mickelson; Joanne van Ryn; Robert P Hebbel; Dougald M Monroe; Nigel Mackman; Nigel S Key; Rafal Pawlinski
Journal:  Blood       Date:  2014-01-21       Impact factor: 22.113

6.  Targeting AnxA1/Formyl Peptide Receptor 2 Pathway Affords Protection against Pathological Thrombo-Inflammation.

Authors:  Shantel A Vital; Elena Y Senchenkova; Junaid Ansari; Felicity N E Gavins
Journal:  Cells       Date:  2020-11-13       Impact factor: 6.600

7.  Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.

Authors:  Paritha I Arumugam; Eric S Mullins; Shiva Kumar Shanmukhappa; Brett P Monia; Anastacia Loberg; Maureen A Shaw; Tilat Rizvi; Janaka Wansapura; Jay L Degen; Punam Malik
Journal:  Blood       Date:  2015-08-18       Impact factor: 22.113

8.  Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis.

Authors:  Elena Y Senchenkova; Shunsuke Komoto; Janice Russell; Lidiana D Almeida-Paula; Li-Sue Yan; Songlin Zhang; D Neil Granger
Journal:  Am J Pathol       Date:  2013-05-11       Impact factor: 4.307

Review 9.  Emerging understanding of roles for arterioles in inflammation.

Authors:  Ronen Sumagin; Ingrid H Sarelius
Journal:  Microcirculation       Date:  2013-11       Impact factor: 2.628

Review 10.  Interplay between coagulation and vascular inflammation in sickle cell disease.

Authors:  Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Br J Haematol       Date:  2013-04-18       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.